Omega-3 Fatty Acids (DHA/EPA) for Cerebrovascular Health

References

1. [1] Kaj Winther. Nutrients. 2026. The Clinical Implications of Ashwagandha (Withania somnifera L.) with a Special Reference to Side Effects-A Review. doi:10.3390/nu18050871 PubMed
2. [2] Hyeongyeong Kim et al.. J Ethnopharmacol. 2025. Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice by enhancing the brain-derived neurotrophic … doi:10.1016/j.jep.2024.119224 PubMed
3. [3] Apeksha Rana et al.. Front Nutr. 2025. Natural sulfur compounds in mental health and neurological disorders: insights from observational and intervention studies. doi:10.3389/fnut.2025.1534000 PubMed
4. [4] Ting Yu et al.. Phytomedicine. 2025. Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of Alzheimer's disease. doi:10.1016/j.phymed.2025.156646 PubMed
5. [5] Madeleine C Nankivell et al.. Nutrients. 2025. Coenzyme Q10 and Cognition: A Review. doi:10.3390/nu17172896 PubMed
6. [6] Nasser M Aldekhail et al.. Altern Ther Health Med. 2025. Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines. PubMed
7. [7] Sanjaay Balakrishnan et al.. Sci Rep. 2025. Systems biology modelling based evaluation of omega-3 formulation in managing cardiovascular and cerebrovascular risk. doi:10.1038/s41598-025-23677-6 PubMed
8. [8] Yaqing Gao et al.. J Affect Disord. 2025. Neuroticism, omega-3 fatty acids, and risk of incident dementia. doi:10.1016/j.jad.2025.119733 PubMed
9. [9] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
10. [10] Weile Ye et al.. Acta Pharm Sin B. 2024. [Not Available]. doi:10.1016/j.apsb.2023.09.014 PubMed
11. [11] Jing Chang et al.. Eur J Nutr. 2024. Effects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild cognitive impairment: a meta-analysis of … doi:10.1007/s00394-024-03324-y PubMed
12. [12] Christa M Frodella et al.. Biomedicines. 2024. Oxytocin and Vasopressin Gene Expression in the Brain as Potential Biomarkers for Cannabidiol Therapeutic Efficacy. doi:10.3390/biomedicines12061273 PubMed
13. [13] Marie-Françoise Vecchierini et al.. Rev Prat. 2024. [Pharmacotherapies for insomnia]. PubMed
14. [14] Domenico Sergi et al.. Int J Mol Sci. 2023. Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides. doi:10.3390/ijms24054403 PubMed
15. [15] Jinxuan Wang et al.. Research (Wash D C). 2022. trans-2-Enoyl-CoA Reductase Tecr-Driven Lipid Metabolism in Endothelial Cells Protects against Transcytosis to Maintain Blood-Brain Barrier Homeostasis. doi:10.34133/2022/9839368 PubMed
16. [16] Gitishree Das et al.. Plants (Basel). 2022. Glucosinolates and Omega-3 Fatty Acids from Mustard Seeds: Phytochemistry and Pharmacology. doi:10.3390/plants11172290 PubMed
17. [17] Sindgi Vasudeva Murthy et al.. Prev Nutr Food Sci. 2022. Hydroalcoholic Extract of Ashwagandha Improves Sleep by Modulating GABA/Histamine Receptors and EEG Slow-Wave Pattern in In Vitro - In Vivo … doi:10.3746/pnf.2022.27.1.108 PubMed
18. [18] Lucille M Yanckello et al.. J Cell Immunol. 2022. Inulin Supplementation Mitigates Gut Dysbiosis and Brain Impairment Induced by Mild Traumatic Brain Injury during Chronic Phase. doi:10.33696/immunology.4.132 PubMed
19. [19] Vincent Beliveau et al.. Neuroimage Clin. 2022. Revisiting brain iron deficiency in restless legs syndrome using magnetic resonance imaging. doi:10.1016/j.nicl.2022.103024 PubMed
20. [20] Paola Di Pietro et al.. Antioxidants (Basel). 2022. A Novel Combination of High-Load Omega-3 Lysine Complex (AvailOm®) and Anthocyanins Exerts Beneficial Cardiovascular Effects. doi:10.3390/antiox11050896 PubMed
21. [21] Misato Ota et al.. J Ethnopharmacol. 2022. Prolonging effects of Valeriana fauriei root extract on pentobarbital-induced sleep in caffeine-induced insomnia model mice and the pharmacokinetics of its … doi:10.1016/j.jep.2022.115625 PubMed
22. [22] Yulin Sun et al.. BMJ Open. 2022. Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial. doi:10.1136/bmjopen-2021-057970 PubMed
23. [23] Jannis Kountouras et al.. Clin Nutr. 2022. Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". doi:10.1016/j.clnu.2022.06.015 PubMed
24. [24] Mauro Manconi et al.. Nat Rev Dis Primers. 2021. Restless legs syndrome. doi:10.1038/s41572-021-00311-z PubMed
25. [25] Heba M A Khalil et al.. J Ethnopharmacol. 2021. Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits in thioacetamide-induced rat model of hepatic encephalopathy via induction of … doi:10.1016/j.jep.2021.114141 PubMed
26. [26] Aleix Sala-Vila et al.. Am J Clin Nutr. 2021. DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease. doi:10.1093/ajcn/nqab016 PubMed
27. [27] Shuang Zhao et al.. Evid Based Complement Alternat Med. 2021. The Clinical Efficacy of Ginkgo biloba Leaf Preparation on Ischemic Stroke: A Systematic Review and Meta-Analysis. doi:10.1155/2021/4265219 PubMed
28. [28] Chen Chen et al.. Asia Pac J Clin Nutr. 2021. Fish consumption, long-chain omega-3 fatty acids intake and risk of stroke: An updated systematic review and meta-analysis. doi:10.6133/apjcn.202103_30(1).0017 PubMed
29. [29] Rodiya Manor et al.. J Ethnopharmacol. 2021. Characterization of pharmaco-EEG fingerprint and sleep-wake profiles of Lavandula angustifolia Mill. essential oil inhalation and diazepam administration in rats. doi:10.1016/j.jep.2021.114193 PubMed
30. [30] Brittany R Block et al.. Sr Care Pharm. 2021. Online Promotion of "Brain Health" Supplements. doi:10.4140/TCP.n.2021.489 PubMed
31. [31] Isabella C Arellanes et al.. EBioMedicine. 2020. Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial. doi:10.1016/j.ebiom.2020.102883 PubMed
32. [32] Nawab John Dar et al.. J Ethnopharmacol. 2020. Neurodegenerative diseases and Withania somnifera (L.): An update. doi:10.1016/j.jep.2020.112769 PubMed
33. [33] Julia C Kuszewski et al.. J Nutr. 2020. Evaluation of Cognitive Performance following Fish-Oil and Curcumin Supplementation in Middle-Aged and Older Adults with Overweight or Obesity. doi:10.1093/jn/nxaa299 PubMed
34. [34] Noriko Shinjyo et al.. J Integr Med. 2020. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. doi:10.1016/j.joim.2020.01.004 PubMed
35. [35] Jennifer L Martin et al.. J Clin Sleep Med. 2020. The Veterans Administration and Department of Defense clinical practice guidelines for the diagnosis and management of sleep disorders: what does … doi:10.5664/jcsm.8486 PubMed
36. [36] A Jaca et al.. S Afr Med J. 2020. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. doi:10.7196/SAMJ.2020.v110i12.14730 PubMed
37. [37] Dan Wu et al.. Zhongguo Zhong Yao Za Zhi. 2020. [Similarities and differences between Ginkgo biloba and Panax notoginseng in treatment of ischemic cerebrovascular disease]. doi:10.19540/j.cnki.cjcmm.20200313.402 PubMed
38. [38] G C Román et al.. Rev Neurol (Paris). 2019. Mediterranean diet: The role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and … doi:10.1016/j.neurol.2019.08.005 PubMed
39. [39] Jason P Rocha et al.. Curr Nutr Rep. 2019. Multiple Health Benefits and Minimal Risks Associated with Vegetarian Diets. doi:10.1007/s13668-019-00298-w PubMed
40. [40] Jerome Sarris et al.. J Psychiatr Res. 2019. L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. doi:10.1016/j.jpsychires.2018.12.014 PubMed
41. [41] Valérie Cochen De Cock et al.. Curr Neurol Neurosci Rep. 2019. Sleep Disorders in Wilson's Disease. doi:10.1007/s11910-019-1001-4 PubMed
42. [42] C Schwarz et al.. J Prev Alzheimers Dis. 2018. Effects of Omega-3 Fatty Acids on Resting Cerebral Perfusion in Patients with Mild Cognitive Impairment: A Randomized Controlled Trial. doi:10.14283/jpad.2017.23 PubMed
43. [43] Jeffery M Reddan et al.. Front Aging Neurosci. 2018. Glycerophospholipid Supplementation as a Potential Intervention for Supporting Cerebral Structure in Older Adults. doi:10.3389/fnagi.2018.00049 PubMed
44. [44] Giovanni Rizzo et al.. Sleep Med. 2017. Brain imaging and networks in restless legs syndrome. doi:10.1016/j.sleep.2016.07.018 PubMed
45. [45] G Iolascon et al.. J Nutr Health Aging. 2017. Are Dietary Supplements and Nutraceuticals Effective for Musculoskeletal Health and Cognitive Function? A Scoping Review. doi:10.1007/s12603-016-0823-x PubMed
46. [46] Amy W Amara et al.. Curr Treat Options Neurol. 2017. Treatment of Sleep Dysfunction in Parkinson's Disease. doi:10.1007/s11940-017-0461-6 PubMed
47. [47] Jennifer L Schroeck et al.. Clin Ther. 2016. Review of Safety and Efficacy of Sleep Medicines in Older Adults. doi:10.1016/j.clinthera.2016.09.010 PubMed
48. [48] Philippa A Jackson et al.. Nutrients. 2016. DHA Supplementation Alone or in Combination with Other Nutrients Does not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older … doi:10.3390/nu8020086 PubMed
49. [49] Maria Kippler et al.. Environ Int. 2016. Associations of dietary polychlorinated biphenyls and long-chain omega-3 fatty acids with stroke risk. doi:10.1016/j.envint.2016.07.012 PubMed
50. [50] Giuseppe Roberto et al.. Basic Clin Pharmacol Toxicol. 2016. Concurrent Use of Low-Dose Aspirin and Omega-3 Fatty Acids and Risk of Upper Gastrointestinal Complications: A Cohort Study with Nested … doi:10.1111/bcpt.12454 PubMed
51. [51] Yoan Cherasse et al.. Mol Nutr Food Res. 2015. Zinc-containing yeast extract promotes nonrapid eye movement sleep in mice. doi:10.1002/mnfr.201500082 PubMed
52. [52] Nicole L Cockayne et al.. Trials. 2015. The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an … doi:10.1186/s13063-015-0762-6 PubMed
53. [53] Valerio Zerbi et al.. Neurobiol Aging. 2014. Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease. doi:10.1016/j.neurobiolaging.2013.09.038 PubMed
54. [54] Léopold K Fezeu et al.. PLoS One. 2014. Baseline plasma fatty acids profile and incident cardiovascular events in the SU.FOL.OM3 trial: the evidence revisited. doi:10.1371/journal.pone.0092548 PubMed
55. [55] Martin F Reiner et al.. Praxis (Bern 1994). 2014. [The effects of Omega-3 fatty acids in clinical medicine]. doi:10.1024/1661-8157/a001593 PubMed
56. [56] Biljana Obrenović-Kirćanski et al.. Srp Arh Celok Lek. 2012. [Atrial fibrillation after coronary artery bypass surgery: possibilities of prevention]. doi:10.2298/sarh1208521o PubMed
57. [57] Mark C Houston. J Clin Hypertens (Greenwich). 2011. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. doi:10.1111/j.1751-7176.2011.00489.x PubMed
58. [58] Robert H Howland. J Psychosoc Nurs Ment Health Serv. 2011. Alternative drug therapies for dementia. doi:10.3928/02793695-20110407-03 PubMed
59. [59] Bernhard Rauch et al.. Circulation. 2010. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted … doi:10.1161/CIRCULATIONAHA.110.948562 PubMed
60. [60] Patrick J G H Kamphuis et al.. J Alzheimers Dis. 2010. Can nutrients prevent or delay onset of Alzheimer's disease? doi:10.3233/JAD-2010-091558 PubMed
61. [61] Klaus P Ebmeier. Practitioner. 2010. Normal cognitive decline or dementia? PubMed
62. [62] Eline M van der Beek et al.. Eur J Pharmacol. 2008. The potential role of nutritional components in the management of Alzheimer's Disease. doi:10.1016/j.ejphar.2008.01.049 PubMed
63. [63] Anna K Morin et al.. Pharmacotherapy. 2007. Therapeutic options for sleep-maintenance and sleep-onset insomnia. doi:10.1592/phco.27.1.89 PubMed
64. [64] Akhlaq A Farooqui et al.. Brain Res Rev. 2007. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. doi:10.1016/j.brainresrev.2007.09.004 PubMed
65. [65] Chun-Su Yuan et al.. Anesth Analg. 2004. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. doi:10.1213/01.ANE.0000096189.70405.A5 PubMed
66. [66] H V Thommasen et al.. Rural Remote Health. 2004. Differences in diabetic co-morbidity between Aboriginal and non-Aboriginal people living in Bella Coola, Canada. PubMed
67. [67] M Malouf et al.. Cochrane Database Syst Rev. 2003. Folic acid with or without vitamin B12 for cognition and dementia. doi:10.1002/14651858.CD004514 PubMed
68. [68] Lauren T Bonner et al.. Med Clin North Am. 2002. Pharmacologic treatments of dementia. doi:10.1016/s0025-7125(02)00007-x PubMed
69. [69] S Logani et al.. Life Sci. 2000. Actions of Ginkgo Biloba related to potential utility for the treatment of conditions involving cerebral hypoxia. doi:10.1016/s0024-3205(00)00741-4 PubMed
70. [70] B Enkvetchakul et al.. Poult Sci. 1995. Influence of diethyl maleate and cysteine on tissue glutathione and growth in broiler chickens. doi:10.3382/ps.0740864 PubMed
71. [71] P Kim et al.. Stroke. 1992. Dietary omega-3 fatty acids and endothelium-dependent responses in porcine cerebral arteries. doi:10.1161/01.str.23.3.407 PubMed